论文信息 - The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones - 字舞流文

The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones

K. Miyoshi | Shingo Nakamura | Satoshi Watanabe | Masahiro Sato | T. Sakurai | Shingo Nakamura